FDA Mixed Messages Create QbD Confusion; Consultant
By: Nick Taylor of in-Pharma Technologist.com
Link provided by in-Pharma Technologist.com, July 2012
Dr. Sheila Magil, Senior Consultant, was interviewed by Nick Taylor of in-Pharma Technologist. com to comment on the results of BPTC’s recent bioPULSE survey, Quality by Design: Just a Buzz Word?